BACKGROUND: Non-adherence with antipsychotic medication is common in patients with
schizophrenia. AIMS: To establish the efficacy of adherence therapy (AT) compared to …

Background: Up to 50% of patients with schizophrenia are non-adherent with antipsychotic
medication. Aims: To establish the efficacy of adherence therapy (AT) compared to treatment …

ObjectiveNonadherence to antipsychotic medication is highly prevalent in patients with
schizophrenia and has a deleterious impact on the course of the illness. This review seeks …

Poor adherence limits the effectiveness of antipsychotic treatment in people with psychosis.
The aim of the pragmatic, exploratory, single‐masked trial conducted in the USA was to …

Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …

Partial and non-adherence to medication is a common problem in schizophrenia, leading to
an increased risk of relapse, increased likelihood of hospitalization and poorer long-term …

BackgroundThere is equivocal evidence of the effectiveness of adherence therapy in
improving treatment adherence and clinical outcomes for people with schizophrenia …

To assess baseline predictors and consequences of antipsychotic adherence during long-
term treatment of schizophrenia outpatients, data were taken from the 3-year, prospective …

Background: Nonadherence to medication is a recognized problem and may be the most
challenging aspect of treatment. Methods: We performed a systematic review of factors that …

Background Current practice guidelines for schizophrenia care recommend that
antipsychotic medication is essential for patients' long-term maintenance treatment but their …